(Cochrane) El beneficio de los antibióticos en la remisión de la enfermedad de Crohn parece ser no clínicamente significativo. https://t.co/LuEpB9LZnF
Antibióticos para el tratamiento de la enfermedad de Crohn Cochrane https://t.co/kfChVK6hV6
.@cochranecollab review: Antibiotics for Induction/Remission in Crohn's Disease: - 10-14 weeks: 41% abx pts failed remission vs 49% placebo (RR 0.77, 95% CI 0.64-0.93) - "high quality evidence suggests no increased risk of AE's in abx compared w/ placebo"
(Cochrane) Antibiotics for induction and maintenance of remission in Crohn`s disease https://t.co/tfQf1rQs7J
A new article out from Cochrane Database of Systematic Reviews called "Antibiotics for induction and maintenance of remission in Crohn's disease". https://t.co/17wgjeNeYw You can get access to this article from your Library Resources.
There's a theme @cochranecollab recently, now for #Crohns https://t.co/WJPIXwYcrt "Moderate to high quality evidence suggests that any benefit provided by antibiotics in active #crohnsdisease is likely to be modest and may not be clinically meaningful."
Antibiotics for the treatment of Crohn's disease | Cochrane review https://t.co/ibogocJ5Lj
Antibiotics for induction and maintenance of remission in Crohn's disease - Townsend, CM - 2019 | Cochrane Library https://t.co/LkU0cQiWnT
Antibiotics for induction and maintenance of remission in Crohn's disease. - PubMed - NCBI https://t.co/rQxkHAlmAK
Yes, but not all antibiotics are created equal. There’s no mention of AMAT that specifically targets MAP. It’s like saying all antibiotics are useless against TB after trying amoxicillin. 40+% gained remission with AMAT in @RedHillBio trial. https://t.co/X